Evaluating the impact of bevacizumab as a targeted therapy in combination with standard  chemotherapy on disease progression and treatment outcomes in ovarian cancer

Segarajasingam Akshayan; Rosa Sellappulige Sadul Visvajith; Rupasinghe Dulki Semini

dc.contributor.author	Segarajasingam Akshayan
dc.contributor.author	Rosa Sellappulige Sadul Visvajith
dc.contributor.author	Rupasinghe Dulki Semini
dc.date.accessioned	2025-11-28T08:47:47Z
dc.date.available	2025-11-28T08:47:47Z
dc.date.issued	2025
dc.identifier.citation	Segarajasingam Akshayan. Evaluating the impact of bevacizumab as a targeted therapy in combination with standard chemotherapy on disease progression and treatment outcomes in ovarian cancer / Segarajasingam Akshayan, Rosa Sellappulige Sadul Visvajith, Rupasinghe Dulki Semini // Международная научно-практическая конференция студентов и молодых ученых "Scientia infinita" приуроченная к 30-летию основания факультета иностранных учащихся Гродненского государственного медицинского университета : сборник материалов, Гродно, 28 марта 2025 г. = International scientific and practical conference "Scientia infinita" dedicated to the 30th anniversary of the medical faculty for international students of the Grodno state medical university, Belarus : collection of abstracts, Grodno, 28 March 2025 / Гродненский государственный медицинский университет, Факультет иностранных учащихся ; редкол.: М. Н. Курбат (отв. ред.), В. В. Воробьев, А. А. Стенько [и др.]. – Гродно, 2025. – С. 104-106. – 1 CD-ROM.	ru_RU
dc.identifier.isbn	978-985-595-981-7
dc.identifier.uri	http://elib.grsmu.by/handle/files/37637
dc.language.iso	en	ru_RU
dc.publisher	ГрГМУ	ru_RU
dc.title	Evaluating the impact of bevacizumab as a targeted therapy in combination with standard chemotherapy on disease progression and treatment outcomes in ovarian cancer	ru_RU
dc.type	Article	ru_RU